Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 1/2008

01-02-2008

Genetics in the context of thrombophilia

Author: Elizabeth A. Varga

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2008

Login to get access

Abstract

Traditionally, genetics is defined as the study of single-gene and chromosomal disorders, inheritance patterns and variation in organisms. Recent developments in molecular genetics have increased our understanding of how genetic traits contribute to common disease. As a result, it is anticipated that genetic technologies will increasingly be integrated into medical practice. Therefore, it is essential that all medical practitioners have an understanding of basic genetic concepts and terminology. The goal of this manuscript is to provide an overview of genetic and genomic terminology in order that health care practitioners may gain a better appreciation of how these concepts may be applied to medical practice. Factor V Leiden, a genetic alteration that results in a hypercoagulable state, is utilized to explore relevant genetic concepts.
Literature
2.
go back to reference Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277:1305–1307PubMedCrossRef Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997) Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 277:1305–1307PubMedCrossRef
4.
go back to reference Klaus J, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG (2004) Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 140:330–337 Klaus J, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG (2004) Factor V Leiden and the risk for venous thromboembolism in the adult Danish population. Ann Intern Med 140:330–337
5.
go back to reference Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89:397–402PubMed Zivelin A, Griffin JH, Xu X, Pabinger I, Samama M, Conard J, Brenner B, Eldor A, Seligsohn U (1997) A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89:397–402PubMed
6.
go back to reference Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B (1999) Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 81:532–537PubMed Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B (1999) Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 81:532–537PubMed
7.
go back to reference Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL Jr (2003) Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 107:1003–1008PubMedCrossRef Donahue BS, Gailani D, Higgins MS, Drinkwater DC, George AL Jr (2003) Factor V Leiden protects against blood loss and transfusion after cardiac surgery. Circulation 107:1003–1008PubMedCrossRef
8.
go back to reference Corral J, Iniesta JA, Gonzalez-Conejero R, Villalon M, Vicente V (2001) Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 97:2979–2982PubMedCrossRef Corral J, Iniesta JA, Gonzalez-Conejero R, Villalon M, Vicente V (2001) Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage. Blood 97:2979–2982PubMedCrossRef
9.
go back to reference Prows C, Prows D (2004) Medication selection by genotype: how genetics is changing drug prescribing and efficacy. AJN 104(5):60–70PubMed Prows C, Prows D (2004) Medication selection by genotype: how genetics is changing drug prescribing and efficacy. AJN 104(5):60–70PubMed
Metadata
Title
Genetics in the context of thrombophilia
Author
Elizabeth A. Varga
Publication date
01-02-2008
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2008
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-007-0055-3

Other articles of this Issue 1/2008

Journal of Thrombosis and Thrombolysis 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.